Our numerous international contacts have enabled us, since the beginning of the health crisis, to provide regions and distributors with the personal protection and antigen tests that are essential in the fight against Covid-19.

Covid -19

Personal Protection

Antigen tests

The Company
With more than 10 years of experience of its team and partners, BIO AMOVIR focuses its research on a new concept of treatment of diseases caused by enveloped viruses such as AIDS, influenza, herpes, Covid-19

Research

Viral Disease

The Company

Created in 2015, BIO AMOVIR is an R&D, Marketing , distribution and creative company specialised in the field of Virology.

Our commitments

BIO AMOVIR health products have a quality level that ensures the safety of patients and the environment.

Corporate

BIO AMOVIR is owned by the SAMFI-INVEST SAS Group, Alain Samson's family holding company, based in Caen, Normandy.
Based on the first research results, an innovative technology has been developed. AMOVIR® Technology, through its barrier action and the stimulation of the immune system, prevents herpes from the very first signs.

Herpes & Cold sores

Medical Device

BIO AMOVIR SAS 179 rue du Poirier 14650 CARPIQUET FRANCE Capital Social : 2 000 000 € - Siret: 812 245 728 00017 ©2020 par BIO AMOVIR SAS. contact: contact@bioamovir.com
Innovating tomorrow's health product
Our numerous international contacts have enabled us, since the beginning of the health crisis, to provide regions and distributors with the personal protection and antigen tests that are essential in the fight against Covid-19.

Covid -19

Personal Protection

Antigen tests

The Company
With more than 10 years of experience of its team and partners, BIO AMOVIR focuses its research on a new concept of treatment of diseases caused by enveloped viruses such as AIDS, influenza, herpes, Covid-19

Research

Viral Disease

The Company

Created in 2015, BIO AMOVIR is an R&D, Marketing , distribution and creative company specialised in the field of Virology.

Our commitments

BIO AMOVIR health products have a quality level that ensures the safety of patients and the environment.

Corporate

BIO AMOVIR is owned by the SAMFI-INVEST SAS Group, Alain Samson's family holding company, based in Caen, Normandy.
Based on the first research results, an innovative technology has been developed. AMOVIR® Technology, through its barrier action and the stimulation of the immune system, prevents herpes from the very first signs.

Herpes & Cold sores

Medical Device

BIO AMOVIR SAS 179 rue du Poirier 14650 CARPIQUET FRANCE Capital Social : 2 000 000 € Siret: 812 245 728 00017 contact: contact@bioamovir.com ©2020 par BIO AMOVIR SAS.
Innovating tomorrow's health product